Skip to Main Content

Paper Details

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
J Neurooncol
27
2019
EGFR, Epidermal growth factor receptor, GBM, GBMs, INTELLANCE-1 and -2, glioblastoma, glioblastomas, patients, tumor, tumor tissue
Author NameAffiliation
Kenneth AldapeToronto General Hospital/Research Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth AldapeToronto General Hospital/Research Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Marica EoliFondazione IRCCS Istituto Neurologico Carlo Besta
Pim J FrenchErasmus MC Cancer Institute
Minesh P MehtaMiami Cancer Institute, Baptist Hospital
Michael A VogelbaumCleveland Clinic
Michael A VogelbaumMoffitt Cancer Center
  • 1 - 9

Datasets

Release 1.2